Category Archives: News

LBG Team members attend Microbiome Connect: Gut Therapeutics

Will Waterfield, Principal Consultant, Sayan Paria, Associate Consultant, and Hisham Nachabe, Analyst, will attend Microbiome Connect: Gut Therapeutics, a conference that provides a forum for professionals who are actively seeking to “overcome challenges in R&D and manufacturing within the gut microbiome field,” on November 17 – 18 at Courtyard by Marriott, Boston Downtown Boutique Hotel.... Read More

Marco Daoura Attends HLTH 2021

Marco Daoura, Principal (Strategic Consulting, Medical Devices, Digital Health and HealthIT), will attend HLTH 2021 on October 17 – 20 at the Boston Convention & Exhibition Center. His attendance at the event, which is “the preeminent event designed for the health industry, bringing together senior leaders to solve healthcare’s most pressing problems and realize the... Read More

Dr. Robert Huebner Speaks at BioKansas Community Forum

LBG is pleased to announce that Dr. Bob Huebner, Principal Consultant, will participate in a panel at BioKansas’ Community Forum entitled “Accelerating Biologics: The Market Landscape and Engineering Advancements” on October 21. He was invited to speak about the current biologics landscape and the future direction of the industry before the panel begins. Dr. Huebner... Read More

BPI Readers' Choice Awards

Latham BioPharm Group Article Wins BPI Readers’ Choice Award!

“Each year BioProcess International publishes over 150 technical and scientific articles focusing on the latest science, technologies, and techniques supporting biopharmaceutical research, development, and manufacturing.” BioProcess International, Your Choices for BPI’s Best Articles, 2021 This year’s rankings were constructed based on views, engagement, and download rates; and led to the selection of the four most popular articles... Read More

Image Description

Pandemic Preparedness and Response Panel

Sponsored by Center for Entrepreneurship, in partnership with the College of Arts and Sciences Department of Biology, Corporate Engagement Office, and TechGROWTH Ohio. November 18, 2020 Robert Huebner, a Principal Consultant with Latham BioPharm Group, participated in a panel discussion hosted by Ohio University this week. The topic was Pandemic Preparedness and Response. Dr. Huebner... Read More


Determining disease severity in patients with COVID-19

Timothy Alcorn co-authored a paper published by Lab on a Chip titled, “Clinical decision support tool and rapid point-of-care platform for determining disease severity in patients with COVID-19†”.  Dr. Alcorn is the Director of Medical Devices and Diagnostics for Latham BioPharm Group and was consulted for his expertise in this area. This paper was also... Read More

Image Description

Latham BioPharm Group adds Dr. Thijs Beuming and expands consulting offering to include In Silico Drug Discovery services.

CAMBRIDGE, MA – February 25, 2020 – Latham BioPharm Group, Inc. (LBG), a premier provider of life science consulting services, today announced the recent addition of Dr. Thijs Beuming to the team to lead In Silico Drug Discovery services.  LBG’s new offering complements existing product development capabilities by providing full service and strategic support for... Read More

Image Description

Watch now! Roundtable Discussion: Cell and Gene Therapies — Keep the Work In-House, or Use a Third Party?

LBG’s Dr. Joseph Rininger, as an industry leader in Cell & Gene Therapies, was invited to participate in a roundtable discussion at BIO International 2019 on this topic.  Questions posed to the panel by BioProcess Insider editor Dan Stanton were:  Is enough manufacturing capacity available? How do companies reduce cost of goods (CoG) and increase manufacturing efficiency? Should a developer build its own capabilities or... Read More